Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT02443077 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02443077
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2024-06-10
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.